Luteal Phase Defect
4
Pipeline Programs
1
Companies
1
Clinical Trials
3
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
3
Early DiscoveryClinical DevelopmentMarket
On Market (3)
Approved therapies currently available
U
PROGESTASERTApproved
progesterone
Unknown Companyintrauterine1976
U
PROGESTERONEApproved
progesterone
Unknown CompanyProgesterone [EPC]oral2017
U
PROMETRIUMApproved
progesterone
Unknown Companyoral1998
Competitive Landscape
1 companies ranked by most advanced pipeline stage
IBSA Institut BiochimiqueSwitzerland - Lugano-Pazzallo
1 program1
ProgesteronePhase 31 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
IBSA Institut BiochimiqueProgesterone
Clinical Trials (1)
Progesterone in Luteal Phase Deficiency
Start: May 2017Est. completion: Dec 2019
Phase 3Withdrawn
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 late-stage (Phase 3) programs — potential near-term approvals
1 companies competing in this space